Bicara Therapeutics (BCAX): Ra Capital Management, L.P. added to its stake +300K shares

7.26M

Shares reported · +300K vs prior quarter

1.5%

Disclosed portfolio weight

$144M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 30, 2026Company filing · Form 8-K · ResultsReported its results
2. May 11, 2026Company filing · Form 8-K · ResultsReported its results

What came next

1. Jul 23, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 23, 2026, Kiran Mazumdar-Shaw resigned from the Board of Directors (the “Board”) of Bicara Therapeutics Inc. (the “Company”) and her position on the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”), effective as of July 28, 2026.”
2. Aug 11, 2026Company filing · Form 8-K · ResultsReported its results
3. Aug 21, 2026Company filing · Form 8-K · Material agreementSigned an important agreement

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Bicara Therapeutics

For Bicara Therapeutics, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BCAX page.

How this filing works

• SEC Form 13F

Other disclosures at Bicara Therapeutics

• SEC Form 144Oct 21, 2026
• SEC Schedule 13GOct 7, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 13, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its BCAX page.